The story of Viagra, formerly marketed by copyright, presents a complex case study for backers considering the drug arena . Despite its groundbreaking success and creation of billions in revenue , the patent end has opened the door for alternative medications, significantly reducing profit potential . This transition raises questions about the c… Read More